Neurocrine Biosciences
NBIX
#1290
Rank
NZ$24.25 B
Marketcap
$239.52
Share price
0.34%
Change (1 day)
17.38%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company